This guide for newly diagnosed patients provides key information to help you understand your options and have informed ...

A new analysis finds that nearly half of head and neck cancer trials go unpublished, particularly those that lack ...

Cancer patients tend to use cannabis to manage side effects of their treatment and ease symptoms such as nausea, pain, insomnia and anxiety. “Research has shown that there is a high rate of cannabis ...

Cancer cells can break down the protective covers around nerves, causing nerve injury that triggers chronic inflammation, leading to immune exhaustion and eventual resistance to immunotherapy, ...

The FDA has granted fast track designation to the investigational drug CRB-701 for recurrent or metastatic head and neck ...

The FDA has granted fast track designation to the antibody-drug conjugate (ADC) CRB-701 for the treatment of recurrent or ...

Human papilloma virus (HPV) causes around 70% of head and neck cancers in the United States, making it the most common cancer caused by the virus, with rates increasing each year.

PDS Biotech has reported final phase 2 data on PDS0101 in the tough-to-treat head and neck cancer setting, linking a combination of the immunotherapy and Keytruda to median overall survival (OS) of 39 ...